TF, Dahili Tıp Bilimleri Bölümü Koleksiyonu
Güncel Gönderiler
-
Short-term prognosis of elderly patients admitted to the coronary care unit: a subgroup analysis of the MORCOR-TURK (mortality and morbidity in coronary care units in Turkiye) trial
(Kare Publishing, 2024)Objective: This subgroup analysis of the MORCOR-TURK (Mortality and Morbidity in Coronary Care Units in Turkiye) trial aimed to determine the short-term prognosis, mortality rates, and predictors for elderly patients ... -
Fatal amphetamine and methamphetamine poisoning due to body packer syndrome: autopsy case
(Istanbul University Press, 2024)People who hide illegal substances in body cavities and pass them through checkpoints are called body packers. With this method, many illegal substances such as cocaine, heroin, hashish, amphetamines, methamphetamine, and ... -
Predictors of acute kidney injury in chronic kidney disease patients treated for cardiovascular disease in the cardiac intensive care unit (MORCOR-TURK subgroup analysis)
(Springer, 2024)Background: Acute kidney injury (AKI) is a common complication in chronic kidney disease (CKD) patients in the cardiac intensive care unit (cardiac ICU). In this study, we aimed to identify predictors of AKI in CKD patients ... -
Current developments in the treatment of postpartum depression: zuranolone
(AVES, 2024)Pregnancy is a period in a woman’s life during which she experiences physiological, psychological, and social changes. These changes can lead to various mental illnesses, including postpartum depression (PPD), which is ... -
Prediction of lesion-based treatment response after two cycles of lu-177 prostate specific membrane antigen treatment in metastatic castration-resistant prostate cancer using machine learning
(Karger, 2024)Introduction: Lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA) therapy is a radionuclide treatment that prolongs overall survival in metastatic castration-resistant prostate cancer (MCRPC). We aimed to predict ... -
Postbiotics as antiinflammatory and immune-modulating bioactive compounds in metabolic dysfunction-associated steatotic liver disease
(Wiley, 2024)Postbiotics, defined as products or metabolic byproducts secreted by live bacteria or released after bacterial lysis, are emerging as promising therapeutic agents for metabolic dysfunction-associated steatotic liver disease ... -
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
(Nature Research, 2024)The studies evaluating the impact of Her2 levels in neoadjuvant setting have conflicting data. The aim of the study was to evaluate the prognostic impact of Her2 status in early triple negative breast cancer(TNBC). In the ... -
Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region
(Elsevier, 2024)Introduction and Objectives: Given the substantial burden of metabolic dysfunction-associated steatotic liver disease (MASLD), there is an urgent need to assess knowledge and awareness levels among physicians. We assessed ... -
The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer
(BMC, 2024)BackgroundThe HER-2 status of breast cancer (BC) has been classified as negative or positive for a long time. Given the efficacy of novel anti-HER2-targeted antibody drug conjugates (ADCs) in HER2-low BC, a distinct subgroup ... -
Uric acid to albumin ratio as a predictive marker for intracoronary thrombus severity in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI)
(Int Scientific Information, 2024)Background: This study assessed the association between a novel inflammatory marker, uric acid (UA)-to-albumin ratio (UAR), and preprocedural intracoronary artery thrombus (ICAT) in ST elevation myocardial infarction ... -
Impact of comorbid polycystic ovary syndrome on clinical and laboratory parameters in female adolescents with metabolic dysfunction-associated steatotic liver disease: a cross-sectional study
(MDPI, 2024)Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) and polycystic ovary syndrome (PCOS) share several pathophysiological mechanisms. While the prevalence of MASLD has been extensively studied in ... -
The relationship between liver fibrosis scores and ascending aortic dilatation
(Medical University Press, 2024)Background and Aims: Non-alcoholic fatty liver disease (NAFLD) is related to an increased atherosclerotic cardiovascular disease (ASCVD) risk. This study investigated a potential relationship between liver fibrosis scores ... -
Magnification of anxiety sensitivity, alexithymia, anger and bodily sensations in patients with migraine headache
(Cukurova University, 2024)Purpose: In this study, alexithymia, anxiety sensitivity, exaggerated physical sensations and anger expression in patients with migraine headache were compared with a healthy control group. Material and Methods: A total ... -
White tea consumption alleviates anthropometric and metabolic parameters in obese patients
(MDPI, 2024)Background and Objectives: Obesity and related disorders are an increasing global health problem. Achieving and maintaining long-term weight loss through lifestyle changes and/or pharmacological interventions have not met ... -
New approaches based on inflammatory indexes in the evaluation of the neoplastic potential of colon polyps
(MDPI, 2024)Colorectal polyps, precursors to colorectal cancer (CRC), require precise identification for appropriate diagnosis and therapy. This study aims to investigate the differences in hematological and inflammatory markers, ... -
Protective effects of trimetazidine and dexmedetomidine on liver injury in a mesenteric artery ischemia–reperfusion rat model via endoplasmic reticulum stress
(MDPI, 2024)Background/Objectives: Acute mesenteric ischemia can lead to severe liver damage due to ischemia–reperfusion (I/R) injury. This study investigated the protective effects of trimetazidine (TMZ) and dexmedetomidine (DEX) ... -
Secukinumab may be an effective treatment option for axial spondyloarthritis and psoriatic arthritis patients with a history of malignancy: multicenter real-life experience from Turkey
(MDPI, 2024)Background: Secukinumab is a monoclonal antibody against interleukin 17 approved for patients with axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), and psoriasis. Treating axSpA and PsA patients with a history ... -
Investigating the hepatic response to orlistat and white tea in rats on a high-fat diet
(MDPI, 2024)High-fat diets have detrimental health impacts that increase the likelihood of developing obesity and metabolic syndrome. This study aimed to examine the potential antioxidant and anti-inflammatory effects of orlistat and ... -
Cardiovascular risk in patients with ankylosing spondylitis
(MDPI, 2024)Objectives: Ankylosing spondylitis (AS) is an autoinflammatory, chronic disease. Patients with AS are at increased risk of cardiovascular disease (CVD). The link between AS and subclinical atherosclerosis is multifactorial ...